Analysts are intrested in these 5 stocks: ( ($VRT) ), ( ($AFRM) ), ( ($SRPT) ), ( ($MU) ) and ( ($PEP) ). Here is a breakdown of their recent ...

In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Sarepta Therapeutics, with a price target of $26.00. Ear cover......

In a report released today, Andreas Argyrides from Oppenheimer maintained a Buy rating on Sarepta Therapeutics, with a price target of $37.00. Argy......

An announcement from Sarepta Therapeutics ( ($SRPT) ) is now available. On December 7, 2025, Sarepta Therapeutics‘ Board of Directors granted equit......

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Scholar Rock Holding (SRRK – Research Report), Twist......